The eight candidate genes—CD72, CHRDL2, DBI, HYAL1, IGFBP3, LRP11, SERPINH1, and SPARCL1—are involved in regulating the tumor immune microenvironment in CRC by modulating various immune cell types. The gene discussed is HYAL1; the disease is neoplasm.